Giving block in the shoulder region to provide better and prolonged pain relief
Not Applicable
- Registration Number
- CTRI/2020/06/025889
- Lead Sponsor
- Pondicherry Institute of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society Of Anesthesiologists (ASA) Physical Status I To II Of Both Gender
Age Between 18 And 60 Years
Body Mass Index (BMI) <25 Kg/M2
Elective forearm and hand surgeries in orthopedic and plastic surgeries
Exclusion Criteria
Allergy to local anesthetics or Nalbuphine
Infection at the injection site
Patients with clinically significant coagulopathy
Preexisting neuromuscular disorders
Severe cardiovascular, or pulmonary disease, renal or hepatic disorder
Pregnancy and lactation
Patients taking medications with opioid or receiving chronic analgesic therapy other than simple analgesics were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the duration of analgesia between ropivacaine and ropivacaine with nalbuphine for supraclavicular brachial plexus blockadeTimepoint: after complete sensory blockade
- Secondary Outcome Measures
Name Time Method To measure the onset of sensory and motor blockade and <br/ ><br>To measure the duration motor blockade between the two study groups <br/ ><br>To measure the amount of rescue analgesia requirement in the first 24 hours <br/ ><br>To measure the hemodynamic changes during the procedureTimepoint: after complete sensory and motor blockade till first resue analgesia